Current events may remind savvy investors of the opening line from Dicken’s immortal novel, A Tale of Two Cities. The massive disruption to everyday life more closely resembles the “worst of times.”
But for buying opportunities, it’s arguably the best of times. (The Motley Fool)
There are bargains to be found in pretty much every sector. Healthcare is no exception. Here are three healthcare stocks that are dirt cheap and appear to be great buys right now.
AbbVie (NYSE:ABBV) shares currently trade at less than 9 times expected earnings. That kind of low valuation might make sense for a company likely to experience an earnings decline, but that’s not the case for AbbVie.
Granted, the big drugmaker faces some headwinds for its top-selling drug, Humira. Biosimilar rivals are already eating into the blockbuster drug’s market share in Europe and will do the same in the U.S. beginning in 2023. However, AbbVie has been planning for this eventuality for years. I think the company’s in good shape to survive and thrive in a post-Humira world.
Keep reading at The Motley Fool.